|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,610 GBX | -8.87% |
|
-7.84% | +10.57% |
| 11:41am | GSK Interim Analysis of Phase III Trial for Blood Cancer Therapy Shows Promise | MT |
| 11:36am | European Midday Briefing : Mood Improves on Fed Rate Cut Hopes | DJ |
May 21 (Reuters) - GSK plc:
* GSK PLC - POSITIVE PHASE III ASTHMA RESULTS FOR DEPEMOKIMAB
* GSK: PRIMARY ENDPOINTS MET IN SWIFT-1 AND SWIFT-2 TRIALS Source text for Eikon: Further company coverage:
| 1st Jan change | Capi. | |
|---|---|---|
| +10.57% | 91.66B | |
| +40.73% | 739B | |
| +31.77% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +14.79% | 240B | |
| +9.52% | 210B | |
| -4.95% | 206B | |
| +6.17% | 164B |
GSK PLC 
